Skip to main content
Erschienen in: International Journal of Colorectal Disease 2/2010

01.02.2010 | Original Article

Clinical significance of pT sub-classification in surgical pathology of colorectal cancer

verfasst von: Marion J. Pollheimer, Peter Kornprat, Verena S. Pollheimer, Richard A. Lindtner, Andrea Schlemmer, Peter Rehak, Cord Langner

Erschienen in: International Journal of Colorectal Disease | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Tumour stage is the strongest prognostic parameter in colorectal cancer. The study aimed to evaluate the prognostic impact of pT2, pT3, and pT4 sub-classification.

Methods

Three hundred eighty-one surgical colorectal cancer specimens were retrospectively re-evaluated. pT2 tumours were sub-classified according to infiltration of the inner circumferential (pT2a) or outer longitudinal (pT2b) layer of the muscularis propria. pT3 tumours were sub-classified by measuring the maximal tumour invasion beyond the outer border of the muscularis propria (pT3a ≤ 1 mm, pT3b > 1–5 mm, pT3c > 5–15 mm, and pT3d > 15 mm). pT4 tumours were sub-classified according to invasion of other organs or structures (pT4a) or perforation of the visceral peritoneum (pT4b). Data were correlated with other pathological parameters and patient outcome.

Results

Seventy pT2 tumours were re-classified as 37 pT2a and 33 pT2b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis. Two hundred eighteen pT3 tumours were re-classified as 49 pT3a, 83 pT3b, 53 pT3c, and 33 pT3d tumours. pT3 sub-classification was significantly associated with tumour grade, angioinvasion, and lymph node involvement and proved to be an independent prognostic variable with respect to progression-free and cancer-specific survival. A cut-off level of 5 mm is recommended. Sixty-five pT4 tumours were re-classified as 15 pT4a and 50 pT4b tumours. There was no significant association with tumour grade, angioinvasion, or lymph node involvement and no significant impact on prognosis.

Conclusions

pT3 sub-classification was significantly associated with patient outcome. In contrast, pT2 and pT4 sub-classification did not show clinical significance.
Literatur
1.
Zurück zum Zitat Compton CC (2007) Optimal pathologic staging: defining stage II disease. Clin Cancer Res 13:6862s–6870sCrossRefPubMed Compton CC (2007) Optimal pathologic staging: defining stage II disease. Clin Cancer Res 13:6862s–6870sCrossRefPubMed
2.
Zurück zum Zitat Compton CC (2006) Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 130:318–324PubMed Compton CC (2006) Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 130:318–324PubMed
3.
Zurück zum Zitat Quirke P, Williams GT, Ectors N et al (2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8:651–657CrossRefPubMed Quirke P, Williams GT, Ectors N et al (2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8:651–657CrossRefPubMed
4.
Zurück zum Zitat Rosen LS, Bilchik AJ, Beart RW Jr et al (2007) New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. Clin Cancer Res 13:6853s–6856sCrossRefPubMed Rosen LS, Bilchik AJ, Beart RW Jr et al (2007) New approaches to assessing and treating early-stage colon and rectal cancer: summary statement from 2007 Santa Monica Conference. Clin Cancer Res 13:6853s–6856sCrossRefPubMed
5.
Zurück zum Zitat Cawthorn SJ, Parums DV, Gibbs NM et al (1990) Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 335:1055–1059CrossRefPubMed Cawthorn SJ, Parums DV, Gibbs NM et al (1990) Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer. Lancet 335:1055–1059CrossRefPubMed
6.
Zurück zum Zitat Willett CG, Badizadegan K, Ancukiewicz M et al (1999) Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167–173CrossRefPubMed Willett CG, Badizadegan K, Ancukiewicz M et al (1999) Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 42:167–173CrossRefPubMed
7.
Zurück zum Zitat Merkel S, Mansmann U, Siassi M et al (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16:298–304CrossRefPubMed Merkel S, Mansmann U, Siassi M et al (2001) The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 16:298–304CrossRefPubMed
8.
Zurück zum Zitat Merkel S, Wein A, Günther K et al (2001) High-risk groups of patients with Stage II colon carcinoma. Cancer 92:1435–1443CrossRefPubMed Merkel S, Wein A, Günther K et al (2001) High-risk groups of patients with Stage II colon carcinoma. Cancer 92:1435–1443CrossRefPubMed
9.
Zurück zum Zitat Steel MC, Woods R, Mackay JM et al (2002) Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 72:483–487CrossRefPubMed Steel MC, Woods R, Mackay JM et al (2002) Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma. ANZ J Surg 72:483–487CrossRefPubMed
10.
Zurück zum Zitat Shinto E, Ueno H, Hashiguchi Y et al (2004) The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum 47:467–473CrossRefPubMed Shinto E, Ueno H, Hashiguchi Y et al (2004) The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer. Dis Colon Rectum 47:467–473CrossRefPubMed
11.
Zurück zum Zitat Harewood GC, Kumar KS, Clain JE et al (2004) Clinical implications of quantification of mesorectal tumour invasion by endoscopic ultrasound: All T3 rectal cancers are not equal. J Gastroenterol Hepatol 19:750–755CrossRefPubMed Harewood GC, Kumar KS, Clain JE et al (2004) Clinical implications of quantification of mesorectal tumour invasion by endoscopic ultrasound: All T3 rectal cancers are not equal. J Gastroenterol Hepatol 19:750–755CrossRefPubMed
12.
Zurück zum Zitat Eriksen MT, Wibe A, Haffner J et al (2007) Prognostic groups in 1, 676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156–167CrossRefPubMed Eriksen MT, Wibe A, Haffner J et al (2007) Prognostic groups in 1, 676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156–167CrossRefPubMed
13.
Zurück zum Zitat Miyoshi M, Ueno H, Hashiguchi Y et al (2006) Extent of mesorectal tumour invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 243:492–498CrossRefPubMed Miyoshi M, Ueno H, Hashiguchi Y et al (2006) Extent of mesorectal tumour invasion as a prognostic factor after curative surgery for T3 rectal cancer patients. Ann Surg 243:492–498CrossRefPubMed
14.
Zurück zum Zitat Cianchi F, Messerini L, Comin CE et al (2007) Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum 50:1332–1341CrossRefPubMed Cianchi F, Messerini L, Comin CE et al (2007) Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model. Dis Colon Rectum 50:1332–1341CrossRefPubMed
15.
Zurück zum Zitat Wittekind Ch, Greene FL, Henson DE, Hutter RVP (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss inc., New York Wittekind Ch, Greene FL, Henson DE, Hutter RVP (eds) (2003) TNM supplement: a commentary on uniform use, 3rd edn. Wiley-Liss inc., New York
16.
Zurück zum Zitat Newland RC, Chapuis PH, Smyth EJ (1987) The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 60:852–857CrossRefPubMed Newland RC, Chapuis PH, Smyth EJ (1987) The prognostic value of substaging colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 60:852–857CrossRefPubMed
17.
Zurück zum Zitat Newland RC, Dent OF, Chapuis PH et al (1995) Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 76:564–571CrossRefPubMed Newland RC, Dent OF, Chapuis PH et al (1995) Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 76:564–571CrossRefPubMed
18.
Zurück zum Zitat Bokey EL, Chapuis PH, Dent OF et al (2003) Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 46:860–866CrossRefPubMed Bokey EL, Chapuis PH, Dent OF et al (2003) Surgical technique and survival in patients having a curative resection for colon cancer. Dis Colon Rectum 46:860–866CrossRefPubMed
19.
Zurück zum Zitat Burdy G, Panis Y, Alves A et al (2001) Identifying patients with T3–T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 44:1682–1688CrossRefPubMed Burdy G, Panis Y, Alves A et al (2001) Identifying patients with T3–T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 44:1682–1688CrossRefPubMed
20.
Zurück zum Zitat Shepherd NA, Baxter KJ, Love SB et al (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102CrossRefPubMed Shepherd NA, Baxter KJ, Love SB et al (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112:1096–1102CrossRefPubMed
21.
Zurück zum Zitat Petersen VC, Baxter KJ, Love SB et al (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51:65–69CrossRefPubMed Petersen VC, Baxter KJ, Love SB et al (2002) Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 51:65–69CrossRefPubMed
22.
Zurück zum Zitat Chapuis PH, Dent OF, Bokey EL et al (2004) Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg 91:349–354CrossRefPubMed Chapuis PH, Dent OF, Bokey EL et al (2004) Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg 91:349–354CrossRefPubMed
23.
Zurück zum Zitat Shepherd NA, Baxter KJ, Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48:849–855CrossRefPubMed Shepherd NA, Baxter KJ, Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48:849–855CrossRefPubMed
24.
Zurück zum Zitat Keshava A, Chapuis PH, Chan C et al (2007) The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 9:609–618CrossRefPubMed Keshava A, Chapuis PH, Chan C et al (2007) The significance of involvement of a free serosal surface for recurrence and survival following resection of clinicopathological stage B and C rectal cancer. Colorectal Dis 9:609–618CrossRefPubMed
25.
Zurück zum Zitat Sobin LH, Wittekind C (eds) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss inc., New York Sobin LH, Wittekind C (eds) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss inc., New York
26.
Zurück zum Zitat Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss inc., New York Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumors, 6th edn. Wiley-Liss inc., New York
27.
Zurück zum Zitat Hamilton SR, Vogelstein B, Kudo S (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the digestive system. IARC Press, Lyon, pp 105–119 Hamilton SR, Vogelstein B, Kudo S (2000) Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumours. Pathology and genetics. Tumours of the digestive system. IARC Press, Lyon, pp 105–119
28.
Zurück zum Zitat Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490CrossRefPubMed Chok KS, Law WL (2007) Prognostic factors affecting survival and recurrence of patients with pT1 and pT2 colorectal cancer. World J Surg 31:1485–1490CrossRefPubMed
29.
Zurück zum Zitat Losi L, Ponti G, Gregorio CD et al (2006) Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol Res Pract 202:663–670CrossRefPubMed Losi L, Ponti G, Gregorio CD et al (2006) Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma. Pathol Res Pract 202:663–670CrossRefPubMed
30.
Zurück zum Zitat Cianchi F, Messerini L, Palomba A et al (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40:1170–1175CrossRefPubMed Cianchi F, Messerini L, Palomba A et al (1997) Character of the invasive margin in colorectal cancer: does it improve prognostic information of Dukes staging? Dis Colon Rectum 40:1170–1175CrossRefPubMed
31.
Zurück zum Zitat Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26:384–389CrossRefPubMed Cianchi F, Palomba A, Boddi V et al (2002) Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 26:384–389CrossRefPubMed
32.
Zurück zum Zitat Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715PubMedCrossRef Krook JE, Moertel CG, Gunderson LL et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324:709–715PubMedCrossRef
Metadaten
Titel
Clinical significance of pT sub-classification in surgical pathology of colorectal cancer
verfasst von
Marion J. Pollheimer
Peter Kornprat
Verena S. Pollheimer
Richard A. Lindtner
Andrea Schlemmer
Peter Rehak
Cord Langner
Publikationsdatum
01.02.2010
Verlag
Springer-Verlag
Erschienen in
International Journal of Colorectal Disease / Ausgabe 2/2010
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-009-0801-4

Weitere Artikel der Ausgabe 2/2010

International Journal of Colorectal Disease 2/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.